History
  • No items yet
midpage
157 F. Supp. 3d 407
D.N.J.
2016
Read the full case

Background

  • Baxter, long-time maker of BREVIBLOC® (ready-to-use esmolol), alleges HQ’s NDA product and patents derive from confidential Baxter work developed by former Baxter scientist George Owoo.
  • Owoo was a named inventor on Baxter patents and left Baxter in early 2010; he had employment and severance agreements with confidentiality and post-employment assignment/noncompete provisions.
  • Within weeks of leaving Baxter, Owoo proposed a ready-to-use esmolol formulation to HQ (via intermediaries) and later contracted with HQ’s affiliate Welgrace; HQ then pursued FDA approval and obtained two patents on its formulation.
  • Baxter sues HQ for patent infringement (separately resolved earlier), and asserted state-law claims against HQ: tortious interference, trade secret misappropriation, unjust enrichment/unfair competition, and correction of inventorship/quiet title based on Owoo’s alleged transfer of Baxter confidential information.
  • The court granted summary judgment to HQ on Baxter’s tortious interference claims (Counts III–IV) but denied summary judgment on misappropriation (Count V), unjust enrichment/unfair competition (Counts VI–VII), and inventorship/quiet title (Counts VIII–IX), finding genuine factual disputes on secrecy, improper acquisition, HQ’s knowledge or willful blindness, and inventorship timing.

Issues

Issue Plaintiff's Argument (Baxter) Defendant's Argument (HQ) Held
Tortious interference with contract/prospective relations HQ knowingly induced Owoo to breach confidentiality/noncompete and interfered with Baxter’s business HQ had no actual knowledge of Owoo’s Baxter contracts; relied on Owoo’s representations and conducted inquiries SJ for HQ — Baxter cannot show required malice/actual knowledge; speculation insufficient
Misappropriation of trade secrets (N.J. Trade Secrets Act) HQ’s product was based on Baxter confidential formulation, HPLC protocols, and osmolality data taken by Owoo; HQ knew or had reason to know of improper acquisition (willful blindness) Baxter’s information was public or independently ascertainable; HQ relied on public sources and Owoo’s assurances; HQ performed its own testing Denied — genuine disputes whether the information qualifies as trade secrets and whether HQ knew or had reason to know of improper acquisition
Unjust enrichment / unfair competition HQ benefited from wrongfully acquired Baxter trade secrets; equitable relief warranted These claims depend on misappropriation; if no misappropriation, no recovery Denied as to summary judgment — factual issues on underlying misappropriation preclude disposal
Correction of inventorship / quiet title Owoo conceived the HQ invention while at Baxter (within assignment window), so Baxter is true owner; HQ’s named co-inventor may be a nominal courtesy HQ contends conception occurred in 2012, after Owoo left; co-inventorship is legitimate Denied — timing and inventorship are fact questions for trial; Owoo’s early proposal creates an inference favoring Baxter

Key Cases Cited

  • Alabama v. North Carolina, 560 U.S. 330 (summary judgment standard)
  • Scott v. Harris, 550 U.S. 372 (view facts in light most favorable to nonmoving party when assessing summary judgment)
  • Halsey v. Pfeiffer, 750 F.3d 273 (3d Cir.) (summary judgment standards and inferences)
  • Celotex Corp. v. Catrett, 477 U.S. 317 (summary judgment burden and necessity of concrete record evidence)
  • Matsushita Elec. Indus. Co. v. Zenith Radio Corp., 475 U.S. 574 (summary judgment where record could not support non-movant)
  • Lamorte Burns & Co. v. Walters, 770 A.2d 1158 (N.J. 2001) (malice requirement for tortious interference requires actual knowledge)
  • Printing Mart-Morristown v. Sharp Elecs. Corp., 563 A.2d 31 (N.J.) (definition of malice and intentional interference)
  • Lightning Lube, Inc. v. Witco Corp., 4 F.3d 1153 (3d Cir.) (defendant cannot be liable for interfering with unknown contract)
Read the full case

Case Details

Case Name: Baxter Healthcare Corp. v. HQ Specialty Pharma Corp.
Court Name: District Court, D. New Jersey
Date Published: Jan 26, 2016
Citations: 157 F. Supp. 3d 407; 2016 WL 344888; 2016 U.S. Dist. LEXIS 9201; Civil Action No. 13-6228 (JBS/KMW)
Docket Number: Civil Action No. 13-6228 (JBS/KMW)
Court Abbreviation: D.N.J.
Log In
    Baxter Healthcare Corp. v. HQ Specialty Pharma Corp., 157 F. Supp. 3d 407